deferoxamine has been researched along with sorbic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ong, CN; Shen, HM; Shen, Y; Shi, CY | 1 |
| Crichton, RR; Della Corte, L; Dexter, DT; Freinbichler, W; Statton, SA; Tipton, KF; Ward, RJ; Weinberger, P; Whitmore, C | 1 |
2 other study(ies) available for deferoxamine and sorbic acid
| Article | Year |
|---|---|
Benzene metabolites enhance reactive oxygen species generation in HL60 human leukemia cells.
Topics: Aldehydes; Benzene Derivatives; Benzoquinones; Carcinogens; Catalase; Deferoxamine; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Free Radical Scavengers; HL-60 Cells; Humans; Hydrogen Peroxide; Hydroquinones; Hydroxyl Radical; Lipid Peroxidation; Phenols; Reactive Oxygen Species; Sorbic Acid; Structure-Activity Relationship; Superoxide Dismutase | 1996 |
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration.
Topics: Animals; Benzoates; Brain; Deferasirox; Deferiprone; Deferoxamine; Free Radicals; Immunohistochemistry; Injections, Intraventricular; Iron Chelating Agents; Male; Microdialysis; Neuroprotective Agents; Parkinsonian Disorders; Pyridones; Rats; Rats, Sprague-Dawley; Sorbic Acid; Triazoles | 2011 |